Journey Medical Corporation Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation (Details)

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation (Details)	12 Months Ended
	Dec. 31, 2023
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS
Options granted	10 years
Minimum
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS
Stock-based compensation option vesting period	3 years
Maximum
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS
Stock-based compensation option vesting period	4 years

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details